The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction

NCT00690261 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2008-06-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the correlation between M1/M2 phenotype of tumor associated macrophage (TAM) in lung cancer patients and clinical outcome.

Conditions

Interventions

OTHER

No intervention in this study

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV
  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chao-Chi Ho · Department of Internal Medicine and Emergency Medicine, National Taiwan University Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Completion
2010-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00690261 on ClinicalTrials.gov